Parkinson’s Foundation expands free, at-home genetic testing initiative
By
Alicia Lasek (f3)
May 06, 2022
The organization is making an effort to connect a broader and more diverse set of candidates to clinical trials.
An Alzheimer’s reality check
By
Tim Mullaney
Nov 12, 2013
Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...
CDC briefing: Top officials talk up vaccine plans, focus on long-term care
By
Alicia Lasek
Oct 22, 2020
Federal health officials touted transparency and nationwide distribution plans while keeping their eye on Phase 1 vaccine recipients, including LTC residents and workers.
Alzheimer’s drug slows mental, functional decline in Eli Lilly trial
By
Alicia Lasek
Jan 12, 2021
Participants who took donanemab for 76 weeks showed 32% slower decline in thinking and daily function compared with those in a placebo group.
AMDA’s new COVID vaccine PowerPoint can help answer resident, staff concerns
By
Alicia Lasek
Dec 09, 2020
A toolkit created by industry clinicians aims to help long-term care operators address questions about getting vaccinated. A PowerPoint presentation is available to share with staff and residents.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.
Drug that targets Alzheimer’s inflammation approved for trial by FDA
By
Alicia Lasek
Feb 09, 2021
An experimental drug meant to treat the “type 3 diabetes” that some scientists believe triggers Alzheimer’s has been approved for a late-stage clinical trial.
Seniors are absent — but necessary — in COVID-19 vaccine trials, experts say
By
Alicia Lasek
Sep 29, 2020
With older adults frequently excluded in COVID-19 clinical trials, investigators are concerned that they will ultimately be denied treatments and vaccines due to safety concerns.
COVID vaccine protects elderly; delivery program has buy-in from nearly all U.S. nursing homes
By
Alicia Lasek
Nov 19, 2020
Fully 99% of skilled nursing facilities nationwide have signed on with the federal Pharmacy Partnership for Long-Term Care Program vaccine delivery initiative, HHS says. The news arrived just as Pfizer...
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.